MustGrow Biologics Corp
XTSX:MGRO
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CA |
|
MustGrow Biologics Corp
XTSX:MGRO
|
29.3m CAD |
Loading...
|
|
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
326.4B USD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
205.6B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.5B EUR |
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
43.9B USD |
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
286.5B CNY |
Loading...
|
|
| DE |
|
BioNTech SE
NASDAQ:BNTX
|
26.7B USD |
Loading...
|
|
| US |
|
United Therapeutics Corp
NASDAQ:UTHR
|
20.3B USD |
Loading...
|
|
| US |
|
Incyte Corp
NASDAQ:INCY
|
20.1B USD |
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
19.9B USD |
Loading...
|
Market Distribution
| Min | -10 058.3% |
| 30th Percentile | 20.4% |
| Median | 33.6% |
| 70th Percentile | 50.5% |
| Max | 717.4% |
Other Profitability Ratios
MustGrow Biologics Corp
Glance View
MustGrow Biologics Corp. engages in the development and commercialization of natural biopesticide products from mustard seed. The company is headquartered in Saskatoon, Saskatchewan. The company went IPO on 2019-07-10. The firm is focused on providing natural science-based biological solutions for high value crops, including fruits and vegetables, and other industries. The company has designed and owns a natural solution, which uses the mustard seed's natural defense mechanism to protect plants from pests and diseases. The product, in granule format, is available across all key United states and by Health Canada's Pest Management Regulatory Agency (PMRA) as a biopesticide for high value crops, such as in fruit and vegetables. The company concentrates on a mustard extract biopesticide in liquid format, TerraMG and could be applied through standard drip or spray equipment, improving functionality and performance features. In addition, the Company's mustard-derived extract technologies could have other applications in several different industries from preplant soil treatment, to weed control, to postharvest disease control and food preservation.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for MustGrow Biologics Corp is 14.5%, which is below its 3-year median of 26.3%.
Over the last 1 years, MustGrow Biologics Corp’s Gross Margin has increased from 5.5% to 14.5%. During this period, it reached a low of 5.5% on Sep 30, 2024 and a high of 75.6% on Dec 31, 2024.
